American media reported that the Federal Food and Drug Administration authorized the use of a new drug to treat early infections with the Coronavirus, and said that it is a monoclonal antibiotic that is active against the Covid-19 virus, and depends on biotechnology in its work.

She added that the new drug, called Sotrovimab, was produced in collaboration between GlaxoSmithKline and Vir Biotechnology.

She said that the new approved treatment is the third that works with antibodies in patients in the early stages of the disease, who are at risk of progressing to severe infection.

She indicated that the study conducted on the drug showed that it has effectiveness in reducing the admission of infected people to hospital or death, and according to the Food and Drug Administration, it is expected that the drug will be effective against mutated versions of the Corona virus.

And those involved in the production of the new drug believe that monoclonal antibodies are likely to be one of the most effective tools to combat the emerging corona virus.

While preventive measures - including vaccines - can reduce the total number of cases, Sotrofimab is an important treatment option for those who become ill and at high risk, allowing them to avoid hospitalization or worse.

Reuters reported that the new drug is not authorized for Corona patients who are hospitalized and need oxygen.

And the US Drug Regulatory Administration has previously approved two other drugs, namely Regen-Cove-2, developed by the "Regeneron" company, in addition to the treatment of the "Eli Lilly" company.

Biden asked intelligence to submit a report on the origin of the virus within 3 months (European)

The origin of the virus

In the context of the continuous search for the origin of the Corona virus, US President Joe Biden said that he had asked the intelligence service to double its efforts to investigate the origin of the new Corona virus, and to prepare a report within 3 months.

Biden added in a statement that the intelligence has two possible scenarios about the origin of the virus, the first of which is that it resulted from human contact with an infected animal, and the second due to an accident of an unintended laboratory leak.

The American website Axios stated that the controversy over the origin of the virus has been active in recent days due to US intelligence information that has not been previously disclosed, indicating that 3 researchers from the Wuhan Institute of Virology in China contracted the disease and were placed in the hospital during the month of November. Second 2019.

Biden’s unusual and public talk of classified and inconclusive assessments of US intelligence revealed a controversy raging within the administration regarding the origin of the virus, and it also gave credence to a theory that the virus may have originated from a Chinese research laboratory.

The pandemic has killed more than 3 million people around the world, and the origin of the virus is still in dispute among experts, after the first known cases appeared in Wuhan, central China, in December 2019.

In a report released in March in cooperation with Chinese scientists, a WHO-led team that spent 4 weeks in and around Wuhan in January and February last said that the virus may have been transmitted from bats to humans via another animal, and that "its emergence is a result. A lab accident is an extremely unlikely trend. "